Skip to main content
Livermore
Livermore
ZHEN

HSBC Holdings PLC

SEC CIK
0000873630
Latest filing
Aug 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by HSBC Holdings PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
382,028
Value
$238.5M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by HSBC Holdings PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026382,028$238.5M0.1%+58,690+18.2%AddedHolders
Q1 2026323,338$249.7M0.1%+4,530+1.4%AddedHolders
Q4 2025318,808$246.2M0.1%−51,157−13.8%ReducedHolders
Q3 2025369,965$208.5M0.1%+7,841+2.2%AddedHolders
Q2 2025362,124$189.9M0.1%−27,474−7.1%ReducedHolders
Q1 2025389,598$246.6M0.2%−44,206−10.2%ReducedHolders
Q4 2024433,804$308.6M0.2%+76,720+21.5%AddedHolders
Q3 2024357,084$375.0M0.2%−8,841−2.4%ReducedHolders
Q2 2024365,925$384.3M0.2%−11,501−3.0%ReducedHolders
Q1 2024377,426$363.2M0.3%+52,414+16.1%AddedHolders
Q4 2023325,012$285.5M0.3%+56,010+20.8%AddedHolders
Q3 2023269,002$221.4M0.2%−33,661−11.1%ReducedHolders
Q2 2023302,663$217.0M0.2%+46,863+18.3%AddedHolders
Q1 2023255,800$210.1M0.3%−1,805−0.7%ReducedHolders
Q4 2022257,605$185.5M0.2%+71,846+38.7%AddedHolders
Q3 2022185,759$128.5M0.2%+28,396+18.0%AddedHolders
Q2 2022157,363$93.5M0.1%+66,224+72.7%AddedHolders
Q1 202291,139$63.5M0.1%−5,791−6.0%ReducedHolders
Q4 202196,930$61.8M0.1%−22,829−19.1%ReducedHolders
Q3 2021119,759$72.6M0.1%−11,919−9.1%ReducedHolders
Q2 2021131,678$73.0M0.1%−134,728−50.6%ReducedHolders
Q1 2021266,406$125.8M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.